Detalhe da pesquisa
1.
Computational drug prediction in hepatoblastoma by integrating pan-cancer transcriptomics with pharmacological response.
Hepatology
; 2023 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37729391
2.
Identification and experimental validation of druggable epigenetic targets in hepatoblastoma.
J Hepatol
; 79(4): 989-1005, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37302584
3.
Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications.
J Hepatol
; 73(2): 328-341, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32240714
4.
Analysis of the reliability of surgeons' ability to differentiate between idiopathic and degenerative spinal deformity in adults radiologically. What descriptive parameters help them decide?
Eur Spine J
; 25(8): 2401-7, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26769036
5.
Identification of IGF2 as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma.
Mol Cancer Ther
; 22(4): 485-498, 2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36780225
6.
The decrease of ß-synuclein in cortical brain areas defines a molecular subgroup of dementia with Lewy bodies.
Brain
; 133(Pt 12): 3724-33, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20959308
7.
Molecular pathology of Lewy body diseases.
Int J Mol Sci
; 10(3): 724-45, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19399218
8.
Differential expression of alpha-synuclein, parkin, and synphilin-1 isoforms in Lewy body disease.
Neurogenetics
; 9(3): 163-72, 2008 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18335262
9.
Identification and characterization of a new alpha-synuclein isoform and its role in Lewy body diseases.
Neurogenetics
; 9(1): 15-23, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-17955272